The efficacy of a two-dose hepatitis B vaccination scheme.
Boland
Greet J
GJ
Department of Gastroenterology, University Medical Centre Utrecht, The Netherlands. G.J.Boland@lab.azu.nl
van Bommel
Toon
T
Rulos-van den Berg
Annemarie
A
van den Berg
Jan P B
JP
van Loon
Anton M
AM
van Hattum
Jan
J
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000906:Antibodies / Q000097:blood; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D005260:Female; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D011446:Prospective Studies; D016896:Treatment Outcome
D000906:Antibodies; D017325:Hepatitis B Vaccines